Tower Research Capital (TRC)’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-827
Closed -$27K – 7001
2022
Q1
$27K Buy
827
+276
+50% +$7.46K ﹤0.01% 3273
2021
Q4
$15K Sell
551
-1,170
-68% -$29.8K ﹤0.01% 4045
2021
Q3
$40K Buy
1,721
+393
+30% +$9.33K ﹤0.01% 3140
2021
Q2
$35K Sell
1,328
-4,026
-75% -$101K ﹤0.01% 3339
2021
Q1
$119K Buy
5,354
+2,791
+109% +$64K ﹤0.01% 2459
2020
Q4
$50K Sell
2,563
-45,639
-95% -$758K ﹤0.01% 3136
2020
Q3
$676K Buy
48,202
+37,018
+331% +$534K 0.01% 1354
2020
Q2
$126K Buy
+11,184
New +$102K 0.01% 2254
2020
Q1
– Sell
-3,089
Closed -$63K – 4252
2019
Q4
$63K Buy
3,089
+301
+11% +$5.63K 0.01% 1199
2019
Q3
$46K Buy
2,788
+2,168
+350% +$37.5K ﹤0.01% 1858
2019
Q2
$10K Buy
+620
New +$12K ﹤0.01% 2585
2019
Q1
– Sell
-107
Closed -$3K – 4512
2018
Q4
$3K Buy
+107
New +$3.56K ﹤0.01% 3264
2018
Q2
– Sell
-4,329
Closed -$172K – 4243
2018
Q1
$172K Buy
4,329
+3,362
+348% +$131K 0.01% 952
2017
Q4
$35K Sell
967
-3,513
-78% -$133K ﹤0.01% 1622
2017
Q3
$183K Buy
+4,480
New +$174K 0.02% 833
2017
Q1
– Sell
-1,800
Closed -$41K – 4184
2016
Q4
$41K Buy
+1,800
New +$42.3K ﹤0.01% 1563
2016
Q3
– Sell
-1,977
Closed -$23K – 4738
2016
Q2
$23K Buy
1,977
+1,686
+579% +$19.7K ﹤0.01% 2132
2016
Q1
$3K Buy
+291
New +$3.27K ﹤0.01% 3202
2015
Q4
– Sell
-1,499
Closed -$17K – 5252
2015
Q3
$17K Buy
1,499
+1,461
+3,845% +$17.9K ﹤0.01% 1901
2015
Q2
$0 Sell
38
-2,358
-98% -$39.2K ﹤0.01% 5233
2015
Q1
$47K Buy
2,396
+2,284
+2,039% +$47.8K 0.01% 1522
2014
Q4
$2K Sell
112
-1,944
-95% -$31.7K ﹤0.01% 3428
2014
Q3
$33K Buy
+2,056
New +$34.9K ﹤0.01% 1904
2014
Q2
– Sell
-821
Closed -$14K – 4813
2014
Q1
$14K Sell
821
-575
-41% -$8.85K ﹤0.01% 2286
2013
Q4
$21K Buy
1,396
+376
+37% +$5.34K ﹤0.01% 2297
2013
Q3
$19K Buy
+1,020
New +$18.4K ﹤0.01% 2738

Other funds holding TVTY

Tower Research Capital (TRC)'s TVTY Position: Q2 2022 in Review

Tower Research Capital (TRC) sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 827 shares — an estimated $27K sold.

Tower Research Capital (TRC) first reported a position in TVTY in Q3 2013 and held it in 26 quarters. The position peaked at $676K in Q3 2020. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.

  • Tower Research Capital (TRC) reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 827 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $27K.
  • Tower Research Capital (TRC) first reported a position in Tivity Health, Inc. Common Stock in Q3 2013 and held it in 26 quarters.
  • Tower Research Capital (TRC)'s Tivity Health, Inc. Common Stock position peaked at $676K in Q3 2020.
  • 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.